Suppression of GATA-3 Nuclear Import and Phosphorylation: A Novel Mechanism of Corticosteroid Action in Allergic Disease by Maneechotesuwan, K et al.
Suppression of GATA-3 Nuclear Import and
Phosphorylation: A Novel Mechanism of Corticosteroid
Action in Allergic Disease
Kittipong Maneechotesuwan¤, Xin Yao, Kazuhiro Ito, Elen Jazrawi, Omar S. Usmani, Ian M. Adcock,
Peter J. Barnes*
Airway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom
Abstract
Background: GATA-3 plays a critical role in regulating the expression of the cytokines interleukin (IL)-4, IL-5, and IL-13 from T
helper-2 (Th2) cells and therefore is a key mediator of allergic diseases. Corticosteroids are highly effective in suppressing
allergic inflammation, but their effects on GATA-3 are unknown. We investigated the effect of the corticosteroid fluticasone
propionate on GATA-3 regulation in human T-lymphocytes in vitro and in vivo.
Methods and Findings: In a T lymphocyte cell line (HuT-78) and peripheral blood mononuclear cells stimulated by anti-CD3
and anti-CD28 in vitro we demonstrated that fluticasone inhibits nuclear translocation of GATA-3 and expression of Th2
cytokines via a mechanism independent of nuclear factor-kB and is due, in part, to competition between GATA-3 and the
ligand-activated glucocorticoid receptor for nuclear transport through the nuclear importer importin-a. In addition,
fluticasone induces the expression of mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1), the endogenous
inhibitor of p38 MAPK, which is necessary for GATA-3 nuclear translocation. These inhibitory effects of fluticasone are rapid,
potent, and prolonged. We also demonstrated that inhaled fluticasone inhibits GATA-3 nuclear translocation in peripheral
blood lymphocytes of patients with asthma in vivo.
Conclusions: Corticosteroids have a potent inhibitory effect on GATA-3 via two interacting mechanisms that potently
suppress Th2 cytokine expression. This novel mechanism of action of corticosteroids may account for the striking clinical
efficacy of corticosteroids in the treatment of allergic diseases.
Please see later in the article for the Editors’ Summary.
Citation: Maneechotesuwan K, Yao X, Ito K, Jazrawi E, Usmani OS, et al. (2009) Suppression of GATA-3 Nuclear Import and Phosphorylation: A Novel Mechanism
of Corticosteroid Action in Allergic Disease. PLoS Med 6(5): e1000076. doi:10.1371/journal.pmed.1000076
Academic Editor: Adnan Custovic, University of Manchester, United Kingdom
Received June 8, 2007; Accepted April 2, 2009; Published May 19, 2009
Copyright:  2009 Maneechotesuwan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Supported by a grant from the Medical Research Council and a nonrestrictive grant from GlaxoSmithKline. KM was funded by the Royal Thai
Government and EJ by the Asmarley Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Abbreviations: FP, fluticasone propionate; GR, glucocorticoid receptor; GRE, glucocorticoid response element; IP, immunoprecipitation; NLS, nuclear localisation
sequence(s); PBMC, peripheral blood mononuclear cell; RT-PCE, reverse transcription PCR; SEM, standard error of the mean; Th2, T helper-2.
* E-mail: p.j.barnes@imperial.ac.uk
¤ Current address: Division of Respiratory Disease and Tuberculosis, Department of Internal Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University,
Bangkok, Thailand.
PLoS Medicine | www.plosmedicine.org 1 May 2009 | Volume 6 | Issue 5 | e1000076
Introduction
Inflammation in allergic diseases such as asthma, rhinitis, and
atopic dermatitis is mediated via expression of the cytokines
interleukin (IL)-4, IL-5, and IL-13 from T helper-2 (Th2) cells. IL-
4 and IL-13 regulate the expression of IgE from B lymphocytes,
whereas IL-5 plays a key role in eosinophilic inflammation [1].
Th2 cytokines are regulated by the zinc finger transcription factor
GATA-3, which is predominantly expressed in Th2 cells [2,3].
GATA-3 determines Th2 cell differentiation and selectively
activates the promoters of IL-4, IL-5, and IL-13 through
chromatin remodelling [4–7]. The key role of GATA-3 in allergic
airway inflammation has been demonstrated in mice by the
reduced release of Th2 cytokines in animals treated with
dominant-negative mutants of GATA-3 and by local application
of antisense oligonucleotides to GATA-3 [8,9]. Furthermore,
conditional knock-out of the Gata3 gene in mice reduces expression
of Th2 cytokines in vitro and in vivo [10], and similar results have
been reported in isolated murine CD4+ lymphocytes [11]. Finally,
knockdown of GATA-3 expression using siRNA in human T cells
results in loss of anti-CD3/CD28-mediated Th2 cytokine
expression [12].
In order for GATA-3 to regulate gene expression, it must
translocate from the cytoplasm into the nucleus to access its target
genes. Enhanced nuclear expression of GATA-3 following T cell
receptor activation was first demonstrated in murine T cells [13]
and was recently confirmed in human T cells following T cell
receptor and co-receptor stimulation [12]. GATA-3 contains a
classical nuclear import signal [14] and is transported into the
nucleus by the nuclear import protein importin-a (also known as
karyopherin-a) [12]. Deletion of a region encompassing the
GATA-3 nuclear localisation sequence (NLS) region in murine
and human cells prevents its nuclear localisation [12,14]. The
affinity of the importin-a–NLS interaction is regulated by
phosphorylation [15], and we have shown that p38 mitogen-
activated protein kinase (MAPK) plays a critical role in
phosphorylating GATA-3 to enhance its interaction with im-
portin-a and subsequent transport into the nucleus [12].
Corticosteroids are highly effective in the treatment of allergic
inflammation, with marked suppression of Th2 cytokines in
airways of patients with asthma [16]. Corticosteroids mediate their
anti-inflammatory effects through binding to glucocorticoid
receptors (GRs), which then translocate to the nucleus where they
interact with glucocorticoid response elements (GREs) in the
promoter regions of steroid-sensitive genes. Alternatively, activated
GR interacts with coactivator molecules to suppress the expression
of inflammatory genes by inhibiting the action of proinflammatory
transcription factors such as nuclear factor-kB (NF-kB) through
the recruitment of co-repressor molecules such as histone
deacetylase-2 [17,18].
Nuclear localisation and retention of GR is mediated through
the nuclear localisation sequences NL1 and NL2 [19], by nuclear
retention signals [20], and by control of nuclear export via a
chromosomal region maintenance 1 (CRM-1) dependent pathway
[21]. NL1, which is similar to the SV40 NLS, binds to importin-a
[22]. NL1 is activated both by glucocorticoid agonists such as
dexamethasone and fluticasone propionate (FP) and by glucocor-
ticoid antagonists such as mifepristone (RU486) [23]. NL1 can be
mutated, and the resulting GR still translocates to the nucleus in
response to ligands, but via interaction with importin 7, an event
that requires an as-yet unknown component [23]. NL2 is poorly
defined, residing in the ligand-binding domain, and much less is
known about its mechanism of GR import [24]. A variety of other
factors are also important for the regulation of GR activation and
nuclear import including chaperones such as Hsp90 and other
immunophilins [24–26] and FK506-binding proteins that may be
linked to dynein and/or peptidylprolyl isomerase [27,28].
However, the molecular basis for the inhibition of Th2
cytokines by corticosteroids is not well understood, because the
genes encoding IL-4, IL-5, and IL-13 do not have any
recognisable GRE sequence [29] and are only partly regulated
by NF-kB in human cells [30–32]. Using overexpression and
CAT-reporter genes, Lavender and colleagues [33] have shown
that GR reduced GATA-3-mediated IL-5 and -13 promoter
activity in human CD4+ T cells. The authors postulated that local
recruitment of GR may alter the ability of GATA-3 either to bind
to its target site, to cause transcriptional up-regulation, or to
maintain an environment that is permissive for transcription.
We therefore investigated the effects of a synthetic corticoste-
roid, FP, on GATA-3 phosphorylation and nuclear translocation
in a T lymphocyte cell line (HuT-78) and in peripheral blood
mononuclear cells activated by anti-CD3 and anti-CD28 antibod-
ies in vitro. We also studied the effects of inhaled fluticasone
therapy on GATA-3 subcellular localization in peripheral blood
mononuclear cells (PBMCs) from patients with asthma.
Materials and Methods
Participants and Study Design
We studied patients with mild asthma who were not treated
with inhaled corticosteroids who had been included in a previously
reported double-blind, placebo-controlled, crossover study with FP
[34]. Seven patients with mild asthma entered the study and were
randomized to receive a single inhalation of FP (100 and 500 mg)
or a matched placebo control via a spacer chamber, and the other
treatment was given after a wash-out period of at least 6 d. Blood
was taken for preparation of PBMCs at 1 and 2 h after drug
administration. All patients gave informed consent and the study
was approved by the Ethics Committee of the Royal Brompton
and Harefield Hospitals NHS Trust. The clinical study was
conducted before the requirement for Clinical Trial Registration.
Antibodies and Reagents
The monoclonal antibodies against human CD3, CD28, GR,
and importin-a were purchased from BD Biosciences (Oxford,
United Kingdom). Rabbit antibodies against human GATA-3 (H-
48) and GR (E-20, sc-1003) were obtained from Santa Cruz
Biotechnology (Santa Cruz, California, United States), polyclonal
rabbit antibodies against phospho-p38 MAP kinase and phospho-
ATF-2 from Cell Signaling Technology (New England Biolabs,
Hertford, UK), monoclonal antibody against phosphoserine (clone
4H4) from Affiniti Research Products (Exeter, UK), and
antibodies against rabbit IgG-conjugated TRITC from Dako
Cytomation (Cambridge, UK). The anti-GR antibody (Clone 41)
from BD Transduction Laboratories (Oxford, UK) was used for
Western blot analysis. All other reagents were purchased from
Sigma (Poole, UK).
Cell Culture and PBMC Isolation
A human T cell line (HuT-78) was purchased from ECACC
European Collection of Cell Culture (Wiltshire, UK) were cultured
as previously described [12]. PBMCs were isolated by density
centrifugation over Ficoll-Hypaque (density, 1.077 g/ml; Amer-
sham Biosciences, Amersham, UK) as previously described [34].
Cells were stimulated with anti-CD3/CD28 (1 mg/ml each) for
1 h at 37uC to stimulate Th2 cytokine release in the presence or
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absence of FP (10212 to 1028M). Cytospins were prepared and
GATA-3 localization determined by confocal microscopy as
previously described [12].
Reverse Transcription PCR
Total RNA was extracted using lysis buffer (RNeasy kit; Qiagen,
Crawley, UK). During RNA purification, genomic DNA was
digested with RNase-free DNase (Amersham Biosciences). Next,
0.5 mg of total RNA was reversed transcribed using the avian
myeloblastosis virus RT (Promega, Southampton, UK). For
relative quantification, RT-PCR was carried out using cDNA
probes. Primers for IL-4 were from Sigma-Genosys (Cambridge,
UK). Sequences of GADPH used are as follows: forward 59-
CCACCCATGGCAAATTCCATGGC, reverse 39-TCTA-
GACGGCAGGTCAGGTCCAC.
Cell Fractionation, Immunoprecipitation, and Western
Blot Analysis
Nuclear and cytoplasmic fractions were prepared as previously
described [35]. Whole cell lysates were prepared in NP-40 lysis
buffer (0.5% Nonidet P-40, 20 mM Tris-HCl [pH 7.5], 150 mM
NaCl) in the presence of complete protease cocktail inhibitor.
Lysates were centrifuged at 4uC for 10 min at 12,000 rpm in an
Eppendorf microcentrifuge to remove cellular debris. Samples were
then immunoprecipitated with either 10 ml of antibody against
GATA-3 or importin-a using A/G agarose slurry in the presence of
protease inhibitor using the Catch and Release methodology
(Upstate Biotechnology, Lake Placid, New York, USA). Western
blot analysis was performed using anti-GATA-3, anti-importin-a,
anti-GR, anti-p-p38 MAP kinase, anti-p-ATF-2, and anti-p-serine.
Immunoreactive proteins were detected using an enhanced
chemiluminescence ECL kit (Amersham Biosciences).
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (IP) was performed as previ-
ously described [12] in HuT-78 T-cells with 2 mg of anti-GATA-3
(Santa Cruz Biotechnology), or isotypic immunoglobulin G as a
non-specific control (Santa Cruz Biotechnology) overnight at 4uC.
Promoter sequences were detected with PCR primers for the IL-5
promoter (2445 to +4): forward 59-TTAATCTAGCCACAGT-
CATAG-39 and reverse: 59-TCATGGCTCTGAAACGTTCTG-
39. PCR was performed using a Hybaid Omnigene thermal cycler
(Hybaid, Ashford, UK) with cycling parameters of 72uC for
10 min, 35 cycles at 94uC for 45 s, 52uC for 45 s, 72uC for 45 s.
GR-GATA-3 In Vitro Competition Assay for Importin-a
(Far-Western ELISA)
Immunoprecipitated importin-a (anti-importin-a, Santa Cruz
Biotechnology) from HuT-78 cells was separated by SDS-PAGE
and purified from the excised gel by electroelution [36]. Similarly,
GATA-3 was isolated from nonstimulated HuT-78 cells or cells
stimulated for 30 min with anti-CD3/CD28 and GR was isolated
from FP (1028 M, 30 min) stimulated HuT-78 cells. These
proteins were subsequently refolded in glycine solution. 100 ml
of importin-a solution (100 ng/ml in TBS) was added to 96-well
plates coated with goat anti-importin-a antibody. After 1 h
incubation, GATA-3 (100 ng/ml in TBS) from stimulated or
unstimulated cells were added to the importin-a-coated wells. GR
(10 or 100 ng/ml in TBS) from stimulated or unstimulated cells
were added to some wells. After a further 1 h incubation, the plate
was washed and incubated with primary antibodies (a mixture of
rabbit anti-GATA-3 and mouse anti-GR, Santa Cruz Biotechnol-
ogy) for 1.5 h, and then incubated with secondary antibodies.
FITC swine anti-rabbit IgG (Dako, Cambridge, UK) was used for
the detection of GATA-3, and rhodamine donkey anti-mouse IgG
(Novus, Littleton, Colorado, USA) was used for the detection of
GR. FITC and rhodamine levels were measured with a fluorescent
micro-plate reader (Bioline, London, UK).
NF-kB Activation
NF-kB binding activity in nuclear extracts was determined using
an ELISA-based kit (Trans-AM p65, Active Motif, Rixensart,
Belgium). In brief, 5 mg of nuclear extracts were incubated with a
plate coated with an NF-kB consensus oligonucleotide. Plates were
washed before addition of an anti-p65 antibody. Antibody binding
was detected with a secondary HRP-conjugated antibody and
developed with TMB substrate. The intensity of the reaction was
measured at 450 nm.
Immunofluorescence Staining
Immunofluorescence staining was performed as previously
described [34]. All staining was performed at room temperature
and under humidification. Cells were collected and cytospins
prepared in a cytocentrifuge (Shandon II, Shandon, Runcorn,
UK). Cells were permeabilized, blocked, and then incubated with
GR (1:50 E-20 Santa Cruz Biotechnology) or anti-GATA-3 (H-48;
Santa Cruz Biotechnology) antibody for 1 h at room temperature.
After three washes in phosphate-buffered saline (PBS), cells were
incubated with tetrarhodamine isothiocyanate–conjugated goat
anti-rabbit antibody (Dako). Cytospins were counterstained with
49,6-diamidino-2-phenylindole dihydrochloride (DAPI), a fluores-
cent blue nuclear indole chromatin stain, and mounted in
PBS:glycerol (50:50). The immunopositive signal was charac-
terised using laser scanning confocal microscopy on a Leica TCS
NT/SP interactive laser cytometer equipped with confocal optics
(Leica Microsystems, Wetzlar, Germany). To determine the
specificity of the antibodies, rabbit serum immunoglobulin (Dako)
and secondary antibodies without the primary were used as
controls. Positively stained nuclei and total cells were counted
(500) on each slide with the observer blinded to the treatment.
GATA-3-GFP Construct
The GATA-3 clone (BC003070) complete cDNA was obtained
from Invitrogen Life Technologies as a 59- EcoRI/39-XhoI insert of
GATA-3 in the pOTB7 vector. GATA-3 was excised from pOTB7
using XhoI digestion and pEGFP-C2 (Clontech, Saint-Germain-en-
Laye, France) was digested with BamHI. DNA was recovered by
phenol extraction and ethanol precipitation, and both the GATA-3
fragment and the pEGFP-C2 vector blunt-ended by incubation
with Klenow (Bioline Bio-27029) for 30 min at 37uC. Klenow was
inactivated by incubation for 10 min at 75uC. DNA was recovered
by phenol extraction and ethanol precipitation, and both the blunt-
ended GATA-3 fragment and the GFP vector were subsequently
digested with EcoRI before the 59-EcoRI/39–blunt end GATA-3
fragment was inserted into the 59-EcoRI/39–blunt ended GFP
vector. Positive clones were confirmed by digestion and size analysis
by 1% agarose gel electrophoresis and by sequencing.
Transfection
HuT-78 cells were transfected with either EP8 or GFP vector
only DNA using solution R, programme V-001 at a ratio of 36106
cells/4 mg DNA for 7–8 h in complete medium (10% bovine serum
in RPMI1640+15 L-glutamine) according to the general Amaxa
protocol for nucleofection. The medium was subsequently changed
to 1% RPMI for 24 h before transfected cells were added to anti-
CD3/CD28 treated wells and live cell videomicroscopy performed.
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Time-Lapse Microscopy
HuT-78 cells expressing GATA-3-GFP were maintained at
37uC in growth medium in a closed FCS2 perfusion chamber
(Bioptechs, Butler, Pennsylvania, USA) combined with an
objective heater (Bioptechs) on the stage a Zeiss Axiovert 200
microscope (Thornwood, New York, USA). Observations were
made by 4061.0 NA oil-immersion objective lens, and fluores-
cence and phase contrast images were gathered using a
Hamamatsu ORCA-ER charged coupled device camera (Bridge-
water, New Jersey, USA) driven by Openlab software (Improvi-
sion, Coventry, UK). Photographs were taken at 0, 30, 60, 120,
and 240 min.
Densitometric Analysis
Densitometry of ECL immunoblots was performed using
Gelworks ID intermediate software (Ultraviolet Products, Cam-
bridgeshire, UK). Briefly, immunoblots were scanned and gates
were drawn tightly around each band. Background values from
each lane were subtracted to normalize each measurement. The
bands were quantified using the Gelworks software. All Western
blots were exposed to film for varying lengths of time, and only
films generating subsaturating levels of intensity were selected for
densitometric evaluation.
Statistical Analysis
Data from three or more independent experiments are
presented as the mean6standard error of the mean (SEM), except
where stated and were compared using GraphPad Prism 4
(GraphPad Software, http://www.graphpad.com). Results were
analysed using one-way ANOVA with Newman-Keuls post test
except for the data from the in vivo inhaled FP study, which was
analysed by Friedman’s test with subsequent Wilcoxson matched
pair signed rank sum test. Data from this analysis are presented as
a box-and-whiskers plot. Friedman’s test was used as three
matched measures were obtained using placebo, 100 mg, and
500 mg of inhaled FP, which had variable baseline levels. We did
Figure 1. Fluticasone propionate down-regulates Th2 cytokine gene expression and inhibits GATA-3 nuclear import. (A) Anti-CD3/
CD28 treatment of HuT-78 cells results in translocation of GATA-3 from the cytoplasm to the nucleus within 30 min. (B) Histone H1 and MEK-1 were
used to confirm distinct separation of cytoplasmic and nuclear extracts in three separate experiments. (C) Western blot analysis of FP-treated HuT-78
cells demonstrated impaired nuclear localization of GATA-3 induced by anti-CD3/CD28 co-stimulation in a time- (at 1028 M FP) and concentration- (at
60 min after stimulation) dependent manner. Cells were pretreated with FP for 30 min prior to stimulation. MEK1 and histone H1 were used to
demonstrate equal cytoplasmic and nuclear loading respectively. Results are presented graphically below as mean6SEM of at least three
independent experiments. *** p,0.001 compared to t = 0. (D) RT-PCR showing that FP inhibits IL-4 and IL-5 mRNA expression in CD3/CD28-
costimulated cells. GAPDH was used as a loading control. Lower panels show graphical analysis of results presented as mean6SEM of at least three
independent experiments. ###p,0.001 compared to control, ***p,0.001 compared to anti-CD3/CD28–stimulated. (E) FP (10 nM) reduces the ability
of anti-CD3/CD28-stimulated GATA-3 to associate with the native IL-5 promoter 60 min after stimulation. Data are also shown graphically as
mean6SEM of three independent experiments. All data were analysed by ANOVA followed by Newman-Keuls post-test.
doi:10.1371/journal.pmed.1000076.g001
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not assume a Gaussian distribution of the data due to the limited
numbers of participants analysed (seven).The null hypothesis was
rejected at p,0.05.
Results
The Effect of Corticosteroids on GATA-3 Nuclear
Translocation and IL-4 mRNA
Corticosteroids are effective in inhibiting GATA-3-regulated IL-
4 gene expression in vitro and in vivo [32]. We therefore
investigated whether corticosteroids affect anti-CD3/CD28–stim-
ulated nuclear import of GATA-3. Stimulation of cells with anti-
CD3/CD28 resulted in a rapid cytoplasmic/nuclear GATA-3
translocation (Figure 1A), confirming our previous results [12]. We
also confirmed a clear separation of nuclear and cytosolic fractions
as indicated by histone H1 and MEK-1 markers (Figure 1B). The
potent topical corticosteroid FP caused sustained loss of nuclear
GATA-3 expression and cytoplasmic retention of GATA-3 at
concentrations ranging from 10212 to 1028 M, which cover the
therapeutic range [37]. This effect was concentration- and time-
dependent, with a peak effect of 11.6-fold at 30 min at a
concentration of 1028 M (Figure 1C) and was associated with
marked reductions in anti-CD3/CD28–stimulated IL-4 and IL-5
mRNA expression (Figure 1D) and a loss of GATA-3 binding to
the native IL-5 promoter (Figure 1E).
Ligand-Activated GR Competes with GATA-3 for Importin-a
We confirmed and extended previous data [20] to show that
ligand-activated GR as well as GATA-3 uses importin-a for its
nuclear import (Figure 2A and 2B). This interaction between GR and
importin-a was significant at concentrations as low as 10212 M and
was maximal with 1028 M FP. Subsequent GR nuclear translocation
was rapid and sustained at significant levels for at least 14 h
(Figure 2B). Using IP-Western blotting we showed that FP at 10212–
Figure 2. Fluticasone propionate reduces GATA-3 association with importin-a and GATA-3 nuclear import. (A) Western blot analysis
demonstrates a time- (at 1028 M FP) and concentration- (at 60 min after stimulation) dependent induction of FP-activated GR interaction with
importin-a (Imp-a). A positive control for GR association with importin is shown. Quantification of the densitometry data is shown below. Each bar
represents mean6SEM of at least three independent experiments. *** p,0.001 compared to control, ### p,0.001. (B) Western blot analysis
demonstrated a time- (at 1028 M FP) and concentration- (at 60 min after stimulation) dependent induction of FP-activated GR nuclear translocation
measured by IP. Quantification of the densitometry data is shown below. Each bar represents mean6SEM of at least three independent experiments.
***p,0.001 compared to control. (C) Western blot analysis of HuT-78 cells treated with FP and anti-CD3/CD28 co-stimulation demonstrated a
concentration-dependent decrease in GATA-3–importin-a association at 20 min. Quantification of the densitometry data is shown below. Each bar
represents mean6SEM of at least three independent experiments. ###p,0.001 compared to control, ***p,0.001 compared to aCD3/CD28-
stimulated cells. (D) GFP-tagged GATA-3 was overexpressed and cells stimulated (b, c) or not (a) for 30 min with anti-CD3/CD28. The effect of 30 min
pretreatment of cells with FP (1028 M, c) is also shown. All data were analysed by ANOVA followed by Newman-Keuls post-test.
doi:10.1371/journal.pmed.1000076.g002
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1028 M decreased the association between GATA-3 and importin-a
induced by anti-CD3/CD28 stimulation in a concentration-depen-
dent manner (Figure 2C). In addition, using GFP-labelled GATA-3
and confocal microscopy we demonstrated that GATA-3 nuclear
import following anti-CD3/CD28 stimulation for 30 min was
attenuated by pretreatment with FP (1028 M) (Figure 2D).
Effect on MKP-1
Dexamethasone inhibits p38 MAPK function in a cell type–
specific manner through the rapid induction of the dual kinase
phosphataseMKP-1 (MAPK phosphatase-1), and this effect lasts for
up to 24 h [28]. FP (1028 M) treatment of HuT-78 cells activated
by anti-CD3/CD28 in vitro significantly decreased p38 MAPK
phosphorylation (Figure 3A) and activity measured by phosphor-
ylation of the downstream target ATF-2 (Figure 3B). This effect was
detected at 30 min and lasted for at least 14 h (Figure 3B). FP
(1028 M) also significantly reduced GATA-3 serine phosphoryla-
tion induced by anti-CD3/CD28 stimulation in both a time- and
concentration-dependent manner (Figure 3C). This reduction in
GATA-3 phosphorylation was also seen with lower concentrations
of FP. We found that FP significantly induced MKP-1 mRNA in
both a time- and concentration-dependent manner, reaching a
plateau at 1028 M after 10 min (Figure 3D and 3E). However, the
effects of FP on GATA-3 nuclear import, importin-a association
and IL-4 mRNA expression are seen at 10,000-fold lower
concentrations (10212 M, see Figure 2).
Using an in vitro competition assay (Figure 4A) utilizing purified
activated GATA-3, importin-a, and activated GR, we demonstrat-
ed that activated GR significantly increased GR-importin-a
association in the presence and absence of activated GATA-3
(Figure 4B). This effect is not mutual, since activated GATA-3 did
not block GR–importin-a association (Figure 4C). These data also
suggest that both activated GR and phospho-GATA-3 can directly
associate with importin-a (Figure 4D) and that activated GR
attenuates the phospho-GATA-3/importin-a interaction in a
concentration-dependent manner (Figure 4E). Together, this
Figure 3. Fluticasone propionate–mediated inhibition of p38 MAP kinase phosphorylation and activation is associated with a
marked down-regulation of GATA-3 serine phosphorylation. (A) Western blot analysis shows that FP (1028 M, 30 min) treatment reduced
dual phosphorylation (threonine-180 and tyrosine-182) of p38 MAPK in anti-CD3/CD28–co-stimulated HuT-78 cells. (B) Time course of the effect of FP
(1028 M) on phosphorylation of activated transcription factor 2 (ATF-2), a measure of p38 MAPK activity. (C) FP-induced inhibition of p38 MAPK
activity is associated with the decrease of anti-CD3/CD28 co-stimulation–induced serine phosphorylation (P-Ser) of GATA-3. For (A–C), quantification
of the densitometry data is also shown. Each bar represents mean6SEM of at least three independent experiments. ###p,0.001 compared to
control, ***p,0.001 compared to aCD3/CD28-stimulated cells. (D) FP induced MKP-1 mRNA in a concentration-dependent manner. All results are
representative of at least three independent experiments and where appropriate expressed as means6SEM, *p,0.05. (E) FP induces MKP-1 mRNA in
a time-dependent manner. Results are representative of two independent experiments. All data except (E) were analysed by ANOVA followed by
Newman-Keuls post-test.
doi:10.1371/journal.pmed.1000076.g003
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suggests that ligand-activated GR may compete with phospho-
GATA-3 for importin-a and thereby limit GATA-3 nuclear import.
Other possible interpretations of our results could include an
effect of FP on GATA-3 nuclear export and/or degradation.
Leptomycin B, which inhibits nuclear export, did not affect the
ability of FP to block GATA-3 nuclear localization (Figure 5A).
Additionally, FP had no effect on whole cell GATA-3 expression
during the time course of these experiments (Figure 5B). Nor did
addition of FP subsequent to anti-CD3/CD28 nuclear transloca-
tion affect GATA-3 nuclear residency (Figure 5C), suggesting that
activated GR does not enhance GATA-3 nuclear export. Finally,
the effect of FP on GATA-3 nuclear import was not nonspecific,
since FP (1028 M) had no effect on p65 nuclear translocation
measured at 60 min (Figure 5D).
The Inhibitory Effect of Corticosteroids on GATA-3 Nuclear
Localization in Primary T Lymphocytes Ex Vivo and In Vivo
Treatment with FP ex vivo demonstrated a concentration-
dependent decrease in the direct interaction between phospho-
GATA-3 and importin-a in PBMCs from patients with asthma
(Figure 6A and 6B), which was significantly inhibited at 10212 M
FP (p,0.001, ANOVA and Newman-Keuls test) and completely
attenuated by 1028 M FP (p,0.001, ANOVA and Newman-
Keuls test).
Our previous T cell line studies indicated that 10212 M FP
suppresses IL-4 and -5 gene expression and attenuated the
interaction of GATA-3 with importin-a (see Figures 1D and 2).
This concentration is close to peak plasma levels obtained from
asthmatic patients treated with inhaled FP (500 mg) [27]. Inhaled
FP (500 mg) treatment of seven steroid-naive asthma patients
significantly reduced GATA-3–importin-a interaction in vivo in a
time-dependent manner. This produced a .90% decrease in
GATA-3–importin-a association at 2 h (median [95% CI], 13,494
[6,828–17,829] versus 879 [597–1,165]; p,0.05 Friedman’s
analysis). However, this did not reach significance using Wilcox-
on’s post-test analysis (W=6.00) probably due to low numbers of
participants. Similar results were observed when GATA-3–
importin-a association was measured (Figure 6C and 6D). The
lower dose of FP (100 mg) was not effective. The attenuated
interaction of GATA-3 did not result from the defective recycling
of importin-a, as a significant decrease in the abundance of
importin-a in the cytoplasmic pool was not detected (Figure 6E).
We further examined whether inhaled FP could affect cellular
localization of GATA-3 in peripheral blood T cells. Treatment
Figure 4. Fluticasone propionate competes with phospho-GATA-3 for importin-a. (A) schematic representation of the in vitro binding
competition assay. (B) GR isolated from FP (1028 M) stimulated cells enhances GR–importin-a binding in the presence (N) and absence (&) of
activated GATA-3. * p,0.05 compared to no activated GR. (C) GATA-3 isolated from anti-CD3/CD28–stimulated cells does not attenuate GR–importin-
a association. *p,0.05 compared to control. (D) Activated GR blocks the ability of purified phospho-GATA-3 isolated from anti-CD3/CD28–stimulated
cells interacting with immobilised importin-a in an in vitro binding assay. *p,0.05 compared to GATA-3 isolated from unstimulated cells. #p,0.05
compared to stimulated GATA-3-importin binding. (E) The effect of activated (N) versus unstimulated (#) GR on attenuation of GATA-3–importin-a
association was concentration-dependent. *p,0.05, **p,0.01 between groups. All results are expressed as mean6SEM of three independent
experiments and analysed by ANOVA followed by Newman-Keuls post-test.
doi:10.1371/journal.pmed.1000076.g004
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with inhaled FP (500 mg) for 2 h significantly increased GR
nuclear translocation (Figure 7A) and concomitantly decreased the
number of nuclear GATA-3 immunoreactive peripheral blood T
cells (37%64.2% versus 58.2%64.95%, p=0.016, W=28.0,
Wilcoxon’s rank test) compared with placebo as measured by
immunocytochemistry (Figure 7A and 7B). This was confirmed by
Western blotting, which also indicated that this effect was both
time- and dose-dependent (Figure 7C and 7D). Thus, inhaled FP
(500 mg) induced significant loss in nuclear GATA-3 at 2 h
(median [95% CI], 0.40 [0.27–0.53] versus 0.14 [0.11–0.19],
p,0.05, W=21.00, Wilcoxon’s rank test) (Figure 7C) and
cytoplasmic GATA-3 levels were enhanced by inhaled FP in a
dose-dependent manner (median [95% CI], 0.0032 [0.0026–
0.0039] versus 0.658 [0.592–0.720], p,0.05, W=221.00,
Wilcoxon’s rank test) (Figure 7D). In addition, FP (500 mg)
inhibited p38 MAPK phosphorylation in primary T cells in vivo at
2 h in samples from two patients (Figure 7E).
Taken together, our data suggest that inhaled FP reduces nuclear
localization of GATA-3 in vivo by acutely inhibiting phospho-
GATA-3–importin association. This effect may be direct, through
competition for importin-a or associated molecules, or secondary to
an effect on p38 MAPK-mediated GATA-3 phosphorylation via
rapid induction of MKP-1. The combination of these two
interacting effects can result in complete suppression of GATA-3
nuclear import and thus Th2 cytokine gene expression.
Discussion
Here we have demonstrated, to our knowledge for the first time,
that corticosteroids may inhibit GATA-3 function and therefore
the transcription of Th2 genes via two distinct but interacting
molecular mechanisms. Firstly, corticosteroid-activated GR ap-
pears to compete with activated GATA-3 for nuclear import via
importin-a, which is required for the nuclear transport of both
GATA-3 and GR. Secondly, corticosteroids at higher concentra-
tions increase the expression of MKP-1, a potent inhibitor of p38
MAPK activity and thereby prevent T cell receptor/co-receptor
activation of p38 MAPK to prevent the phosphorylation of
GATA-3 that is necessary for interaction with importin-a and
subsequent nuclear import.
We have previously shown that translocation of GATA-3 from
the cytoplasm to the nucleus involves the nuclear transporter
protein importin-a, which interacts with phosphorylated GATA-3
[12]. We have also previously reported that GATA-3 knockdown
using siRNA results in suppression of anti-CD3/CD28–stimulated
IL-4/IL-5 mRNA induction, thus implicating an essential role for
GATA-3 in the transcription of these genes [12]. We now confirm,
in human T cells, that GR also uses the same nuclear import
mechanism as GATA-3 [22]. We therefore propose that there is
competition between ligand-activated GR and phospho-GATA-3
for nuclear import. Furthermore, we have shown that there is
preferential binding of importin-a to activated GR over phospho-
GATA-3, so that corticosteroids would preferentially reduce
GATA-3 entry and thus rapidly switch off Th2 gene transcription
without any need for any intermediate steps. Furthermore, there
was some degree of specificity for GATA-3, as nuclear
translocation of the p65 subunit of NF-kB was not affected by
corticosteroid exposure.
We tested some alternative explanations for this effect of FP on
GATA-3 nuclear exclusion and failed to show that FP either
enhances GATA-3 nuclear export directly or induces GATA-3
degradation. The evidence from the in vitro competition assays
Figure 5. Fluticasone propionate does not affect GATA-3 nuclear export. (A) Western blot analysis showing that the nuclear export inhibitor
leptomycin B (2 nM) does not affect the ability of FP (1028 M) to prevent anti-CD3/CD28–stimulated GATA-3 nuclear localization measured at 60 min.
***p,0.001 compared to unstimulated cells, ###p,0.001 compared to anti-CD3/CD28–stimulated cells. (B) Western blot analysis showing that FP
(1028 M) does not affect whole-cell GATA-3 degradation over 17 h. (C) GFP-tagged GATA-3 is overexpressed and cells stimulated (b–j) or not (a) with anti-
CD3/CD28. The effect of treating cells with FP (1028 M, f–j) after 30 min stimulation with anti-CD3/CD28 is also shown. (D) FP (1028 M) does not prevent
anti-CD3/CD28–stimulated p65 nuclear translocation at 60 min after stimulation. **p,0.01 compared to unstimulated cells. All results are representative
of at least four independent experiments and are shown as mean6SEM. Results were analysed by ANOVA followed by Newman-Keuls test.
doi:10.1371/journal.pmed.1000076.g005
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does, however, suggest that purified activated GR can clearly
attenuate purified phospho-GATA-3–importin-a association and
that the converse does not occur. Furthermore, we have shown
that only phospho-GATA-3 can associate with importin-a. This
mechanism is sensitive to very low concentrations of corticosteroid
and would be rapid in onset as no changes in protein synthesis are
required. This acute mechanism may also contribute to the
reduction in GATA-3 nuclear import and may play a major role at
low corticosteroid concentrations and/or at early time points prior
to MKP-1 induction.
Corticosteroids can modulate p38 MAPK activity through the
induction of MKP-1, a potent endogenous inhibitor of MAPK
function [38,39]. We report here a rapid induction of MKP-1
mRNA following stimulation of cells with relatively high
concentrations of FP. We hypothesize that this rapid induction
of MKP-1 can reduce GATA-3 nuclear import by attenuating p38
MAPK activity and subsequent GATA-3 phosphorylation, thus
preventing nuclear translocation. The location of the serine
residue(s) of GATA-3 that are phosphorylated by p38 MAPK
are currently unknown, but a bioinformatics search (Motif
Scanner, http://scansite.mit.edu/motifscan_seq.phtml) indicates
at least three potential p38 MAPK-sensitive serine residues.
As predicted from these in vitro data, impairment of GATA-3
nuclear import by FP may, at least in part, underlie the efficacy of
corticosteroids in suppressing allergic inflammation. Although we
did not assess the acute inhibitory effect of FP on the expression of
IL-4 mRNA in vivo, a single inhalation of FP (500 mg) may have
comparable effects, as it provides plasma levels within a relevant
range of concentrations used to suppress IL-4 transcription in our
in vitro system [37]. A lower dose of inhaled FP (100 mg) was not
effective, but plasma concentrations may be below those required
for GATA-3 inhibition. However, it is likely that the higher
concentrations of FP in the airways after inhaled administration
would be effective in inhibiting GATA-3 in airway T cells of
asthma patients. The study of PBMCs from asthma patients
treated with inhaled corticosteroid therapy clearly demonstrates
that these molecular mechanisms are likely to also occur in
patients at therapeutic doses of inhaled corticosteroids. In
addition, previous studies have shown that corticosteroids can
suppress IL-4 and IL-5 release from peripheral blood cells of
asthma patients in vitro and in vivo [40–42].
In summary, our data provide evidence for a novel action of
corticosteroids: suppression of allergic inflammation through a
rapid inhibitory effect on GATA-3 nuclear translocation by
preferential binding to the shared nuclear import protein
importin-a and by a second mechanism involving increased
synthesis of MKP-1, which inhibits p38 MAPK, thus preventing
the phosphorylation of GATA-3 that is necessary for nuclear
Figure 6. Fluticasone propionate impairs GATA-3 interaction with importin-a and GATA-3 nuclear localization in vivo and ex vivo.
(A and B) Co-immunoprecipitation analysis of PBMCs from steroid-naı¨ve asthma patients treated with FP in vitro demonstrated impaired interaction
between GATA-3 and importin-a measured at 60 min. Each bar represents the mean6SEM of at least three independent experiments; *** p,0.001
compared with control as determined by ANOVA/Newman-Keuls analysis. (C and D) Co-immunoprecipitation analyses of PBMCs from steroid-naı¨ve
asthma patients treated with inhaled FP (500 mg via a spacer) in vivo demonstrated decreased association between GATA-3 and importin-a. The
individual values for each treatment are presented graphically. (E) Representative Western blot showing that importin-a expression was unaffected
by inhalation of FP. Blot is representative of gels from three participants.
doi:10.1371/journal.pmed.1000076.g006
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translocation of GATA-3. These two mechanisms are likely to be
synergistic, accounting for the rapid and potent effect of
corticosteroids on allergic inflammation. This is exemplified by
the rapid inhibitory effect of topical corticosteroids on nasal Th2
cytokine release after allergen provocation in individuals with
seasonal allergic rhinitis (hay fever) [43]. Prevention of phospho-
GATA-3 interaction with importin-amay provide a new approach
for the development of novel therapies for the treatment of allergic
diseases.
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Editors’ Summary
Background. The immune system protects the human
body from viruses, bacteria, parasites, and fungi. When one
of these foreign invaders enters the body, immune system
cells called T lymphocytes recognize specific molecules on
the invader’s surface and release chemical messengers
(cytokines) that recruit and activate other types of immune
cell, which then attack the invader. Sometimes, however, the
immune system responds to a normally harmless material
(for example, house-dust mites or grass pollen; scientists call
these materials allergens) and triggers an allergic disease
such as asthma or hay fever. Contact with an allergen
activates a type of T lymphocyte called a T helper-2 (Th2) cell
that subsequently makes (expresses) three cytokines called
interleukin-4 (IL-4), IL-5, and IL-13. These cytokines ultimately
cause inflammation (swelling) of the part of the body
exposed to the allergen. Corticosteroids, which suppress the
expression of cytokines by Th2 cells, are often used to treat
inflammation in allergic diseases. Other treatments for these
common conditions—about 50 million people in the US
have an allergic disease—include minimizing exposure to
allergens and diminishing the response of the immune
system to allergens by using various immunotherapies.
Why Was This Study Done? Scientists know that
corticosteroids reduce allergic inflammation by binding to
proteins in immune system cells called glucocorticoid
receptors. After binding to a corticosteroid, these receptors
move into the nucleus of the cell (the part of the cell that
contains its genes), where they suppress the expression of
certain proinflammatory genes. However, it is still not known
how corticosteroids inhibit the expression of Th2 cytokines.
A key regulator of the expression of these cytokines and of
allergic inflammation is a transcription factor called GATA-3.
Transcription factors are proteins that control the expression
of other proteins by binding to specific sequences in the
genes that encode them. In this study, the researchers try to
discover more about how corticosteroids reduce allergic
inflammation by investigating the effects of the
corticosteroid fluticasone on the regulation of GATA-3
activity in T lymphocytes.
What Did the Researchers Do and Find? Transcription
factors have to move into the nucleus of cells (so-called
nuclear translocation) to control the expression of their
target genes, so the researchers first asked whether
fluticasone affects the cellular localization of GATA-3.
Fluticasone treatment of activated T lymphocytes growing
in dishes, they report, inhibited the nuclear translocation of
GATA-3 and reduced Th2 cytokine expression. Other
experiments showed that the inhibition of GATA-3 nuclear
translocation was partly caused by competition between the
glucocorticoid receptor bound to fluticasone and GATA-3 for
binding to importin-a, a protein that is required for nuclear
import. However, fluticasone also prevented the nuclear
translocation of GATA-3 in a second way. Before GATA-3 can
bind to importin-a, phosphate groups have to be added to
specific sites in GATA-3. This ‘‘phosphorylation’’ requires an
enzyme called p38 MAP kinase, and the researchers found
that fluticasone treatment of activated T lymphocytes
induced the expression of MAP kinase phophatase-1, a p38
MAP kinase inhibitor. Finally, when the researchers treated
seven patients with mild asthma with inhaled fluticasone,
they found that fluticasone also inhibited GATA-3 nuclear
translocation in the lymphocytes circulating in the patients’
blood.
What Do These Findings Mean? These findings, obtained
both in the laboratory and in patients, suggest that
corticosteroids inhibit the expression of Th2 cytokines and
thus reduce allergic inflammation through two interacting
mechanisms. They suggest that corticosteroids prevent the
nuclear translocation of GATA-3, a key regulator of Th2
cytokine expression, by competing with GATA-3 for binding
to importin-a and by preventing the phosphorylation of
GATA-3, a modification that allows GATA-3 to bind to
importin-a. This dual mechanism of corticosteroid action
may help to explain why these drugs are so effective in the
treatment of allergic diseases, although further experiments
are needed to show that the lymphocytes resident at sites of
allergic inflammation respond to corticosteroids in the same
way as lymphocytes in the blood. Finally, these findings
suggest that the interaction between phosphorylated GATA-
3 and importin-a might be a potential target for new
treatments for allergic diseases.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000076.
N The US National Institute of Allergy and Infectious Diseases
provides information on allergic diseases and a simple
description of the immune system
N The UK National Health Service Choices service provides
information about allergies
N Links to other information about allergies are available
from MedlinePlus (in English and Spanish)
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